propidium has been researched along with mitoxantrone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archelos, JJ; Hartung, HP; Hemmer, B; Kieseier, BC; Neuhaus, O; Stüve, O; Wiendl, H | 1 |
Jedrzejczak, M; Jóźwiak, Z; Kania, K; Koceva-Chyła, A; Skierski, J | 1 |
2 other study(ies) available for propidium and mitoxantrone
Article | Year |
---|---|
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Topics: Adult; Annexin A5; Blood Cells; Cell Death; Cell Differentiation; Cells, Cultured; Cytokines; Dendritic Cells; Dose-Response Relationship, Drug; Drug Interactions; Female; Flow Cytometry; Gene Expression; Humans; Immunosuppressive Agents; In Vitro Techniques; Male; Matrix Metalloproteinases; Mitoxantrone; Multiple Sclerosis; Neurotoxins; Propidium; T-Lymphocytes; Tetanus Toxin; Thymidine; Tritium | 2005 |
Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
Topics: Aclarubicin; Animals; Antineoplastic Agents; Apoptosis; Bisbenzimidazole; Caspase 3; Caspase Inhibitors; CHO Cells; Cricetinae; Cricetulus; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Mice; Mitoxantrone; Necrosis; NIH 3T3 Cells; Oligopeptides; Propidium; Time Factors | 2005 |